返回
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.（02315.HK）價格
02315.HK 股價走勢圖
BIOCYTOGEN-B (02315.HK)
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HK$37.84
-5.49%
$-2.19
休市： Jan 20, 16:00:00 HKT
關鍵數據
前收市價
$39.72
開盤價
$40.04
當日範圍
$37.56 - $41
52週區間
$7.07 - $38.8
交易量
622.5K
平均成交量
689.4K
每股盈餘 (TTM)
0.37
股息收益率
--
市值
$4.0B
什麼是 BIOCYTOGEN-B？
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. The company is headquartered in Beijing, Beijing and currently employs 1,306 full-time employees. The company went IPO on 2022-09-01. The firm utilizes its self-developed RenMice fully human antibody and T-cell receptor (TCR) mouse platform for large-scale drug discovery and development targeting potential drug targets in the human body. The Company’s main businesses include the sale of innovative animal models, pre-clinical pharmacology and efficacy evaluation services, and antibody development. The firm is also engaged in the provision of gene-editing services. The firm operates its businesses in the domestic market and overseas markets.